Analyst Ratings February 23, 2026

UBS Lifts Hilton Price Target on Strong Unit Growth Outlook and Revised Valuation Window

Analyst raises target to $360, cites higher unit growth for 2026-2028 and moves valuation horizon to 2028

By Marcus Reed HLT
UBS Lifts Hilton Price Target on Strong Unit Growth Outlook and Revised Valuation Window
HLT

UBS increased its price target for Hilton Worldwide Holdings Inc. to $360 from $312 and kept a Buy rating after updating its model following Hilton's fourth-quarter results. The bank extended its valuation year to 2028, shifted to the upper end of a 17-19x EV/EBITDA multiple range, and cited higher unit growth estimates for fiscal 2026-2028. Hilton currently trades at $315.96 with a market capitalization of $72.45 billion and an EV/EBITDA multiple of 29.73. A separate analysis flags the stock as appearing overvalued relative to its Fair Value even as a dozen analysts have raised earnings estimates.

Key Points

  • UBS raised its price target on Hilton to $360 from $312 and kept a Buy rating; shares trade at $315.96 with a $72.45 billion market cap.
  • The firm updated its model after Hilton's Q4 report, citing higher unit growth estimates for fiscal 2026-2028 and moving the valuation year to 2028 while using the upper end of a 17-19x EV/EBITDA range.
  • Hilton beat Q4 fiscal 2025 estimates with adjusted EPS of $2.08 and revenue of $3.09 billion, but the stock saw a slight pre-market decline, reflecting mixed investor sentiment.

UBS has raised its price target on Hilton Worldwide Holdings Inc. to $360 from $312 while retaining a Buy rating on the shares. The stock was trading at $315.96 and the company had a market capitalization of $72.45 billion at the time of the update.

The firm revised its financial model after reviewing Hilton's fourth-quarter earnings report. The uplift to the price target is driven explicitly by higher unit growth projections for fiscal years 2026 through 2028, according to UBS's updated assumptions.

In its valuation update UBS rolled forward the terminal valuation year to 2028 from 2027 and discounted that back to present value. The bank also shifted its applied multiple range higher, now using the upper end of a 17 to 19 times enterprise value-to-EBITDA range, compared with the 15 to 18 times range it had applied previously.

Market pricing for Hilton currently shows an enterprise value-to-EBITDA multiple of 29.73, a figure UBS characterizes as reflecting the company's premium valuation in the market. UBS noted that this multiple aligns with where Hilton has traded over the past three, five and 10 years and that those periods better reflect Hilton's largely asset-light business model.

The firm pointed out that Hilton's average EV/EBITDA multiple has increased over time as the company reduced its direct property ownership to roughly 1% of the portfolio today, a shift toward franchising and management that tends to support higher multiples in relative terms.

Separately, a third-party valuation analysis indicates the stock appears overvalued relative to its Fair Value even as 12 analysts have recently revised their earnings estimates upward. The analysis cites additional tips and comprehensive valuation metrics available through a proprietary Pro Research Report for those seeking deeper detail.

Hilton's fourth-quarter fiscal 2025 results underpinned the modeling updates. The company posted adjusted earnings per share of $2.08, beating an expectation of $2.02. Revenue for the quarter came in at $3.09 billion, ahead of the $2.99 billion analysts had anticipated.

Despite the positive earnings and revenue surprise, the company's stock experienced a slight pre-market decline, signaling mixed investor sentiment following the release. The results nevertheless illustrate a robust operating performance in the final quarter of the year.

Analysts and investors are likely to continue tracking Hilton's performance and the assumptions that underpinned UBS's revised target - notably the unit growth forecast for fiscal 2026-2028 and the elevated multiple now applied in the valuation.


Key points

  • UBS raised its Hilton price target to $360 from $312 and maintained a Buy rating; current share price is $315.96 and market capitalization is $72.45 billion.
  • The upgrade reflects higher unit growth assumptions for fiscal years 2026-2028 and a roll-forward of the valuation year to 2028, with UBS moving to the upper end of a 17-19x EV/EBITDA range.
  • Hilton reported Q4 fiscal 2025 adjusted EPS of $2.08 versus $2.02 expected and revenue of $3.09 billion versus $2.99 billion expected, yet the stock saw a modest pre-market decline.

Risks and uncertainties

  • Valuation risk - The company's market EV/EBITDA multiple of 29.73 is well above the multiple UBS now applies and a third-party analysis flags the stock as appearing overvalued relative to Fair Value; this affects equity investors and broader market sentiment.
  • Forecast risk - UBS's price target depends on higher unit growth projections for fiscal 2026-2028; if unit expansion falls short, implied valuation support could weaken, impacting hospitality sector investment cases.
  • Market reaction uncertainty - Despite stronger-than-expected quarterly results, the stock dipped pre-market, indicating investors may weigh execution and forward guidance differently than headline earnings and revenues.

Risks

  • Valuation appears elevated - market EV/EBITDA of 29.73 is high relative to applied valuation ranges and a separate analysis indicates the stock may be overvalued, which could pressure investor returns in the hospitality sector.
  • Dependency on unit growth assumptions - UBS's higher price target relies on increased unit growth for 2026-2028; shortfalls in expansion would undermine the revised valuation, affecting hotel owners and franchise/management models.
  • Market reaction uncertainty - The muted or negative immediate market response to a positive earnings surprise highlights the risk that near-term investor sentiment can diverge from reported fundamentals, impacting short-term equity performance.

More from Analyst Ratings

Roth/MKM Upholds Buy on CoreWeave Ahead of Q4 Results, Flags Liquidity and Delivery Metrics Feb 23, 2026 Stifel Lifts Oil States Target to $15 After Q4 Results and 2026 Guidance Feb 23, 2026 Raymond James Sees Early Rotation Toward Risk-On Assets as Seasonal Weakness Fades Feb 23, 2026 Bernstein Sticks With Outperform on Datadog After Analyst Day; $180 Price Target Reaffirmed Feb 23, 2026 Keefe Bruyette & Woods Affirms Outperform on MVB Financial; Cites Strong Revenue Momentum Feb 23, 2026